valproic acid has been researched along with sulfobromophthalein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Gregus, Z; Klaassen, CD; Thompson, TN; Watkins, JB | 1 |
3 other study(ies) available for valproic acid and sulfobromophthalein
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
Topics: Animals; Bile; Ether; Ethyl Ethers; Female; Galactosamine; Glucuronosyltransferase; Liver; Phenolphthaleins; Rats; Rats, Inbred Strains; Sulfobromophthalein; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Sugars; Valproic Acid | 1983 |